Your browser doesn't support javascript.
loading
Toxic Epidermal Necrolysis After COVID-19 Vaccination: A Case Report and Review of Literature.
Wali, Sachin; Gutte, Shreyas; Pandey, Gaurav; Kumar, Ajit; Gurjar, Mohan; Chahar, Jitendra Singh.
Affiliation
  • Wali S; Sanjay Gandhi Postgraduate Institute of Medical Sciences Department of Critical Care Medicine Lucknow India.
  • Gutte S; Sanjay Gandhi Postgraduate Institute of Medical Sciences Department of Critical Care Medicine Lucknow India.
  • Pandey G; Command Hospital Air Force Department of Anaesthesiology and Critical Care Bengaluru India.
  • Kumar A; Sanjay Gandhi Postgraduate Institute of Medical Sciences and Research Centre Consultant Dermatology Lucknow India.
  • Gurjar M; Sanjay Gandhi Postgraduate Institute of Medical Sciences Department of Critical Care Medicine Lucknow India.
  • Chahar JS; Sanjay Gandhi Postgraduate Institute of Medical Sciences Department of Critical Care Medicine Lucknow India.
J Acute Med ; 14(2): 94-97, 2024 Jun 01.
Article in En | MEDLINE | ID: mdl-38855049
ABSTRACT
Following vaccination for COVID-19, various cutaneous adverse reactions (CARs) are reported. Here is an Asian male in late 50's who developed necrotic skin with mucosal involvement 10 days following booster dose of ChAdOx1 nCov-19 vaccination. Based on disease course and morphology, toxic epidermal necrolysis (TEN) was suspected. The patient developed respiratory distress and was intubated, intravenous immunoglobulin (IVIG) administered at 2 g/kg body weight following which skin lesions healed in fourth week, the patient was discharged after 50 days of intensive care unit (ICU) stay. Severe CARs are rare following vaccination, of two components in ChAdOx1nCoV-19 adenoviral vector vaccine, virotopes cause T-cell mediated granulysin and granzyme B release leading to epidermal detachment and mucosal involvement of conducting airways causing respiratory failure. CARs can also occur in whom first and second dose was uneventful. Supportive therapy and prevention of sepsis are mainstay of management. Though the use of IVIG has shown conflicting results, our case was successfully managed with IVIG.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Acute Med Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Acute Med Year: 2024 Document type: Article Country of publication: